RLX Technology stock rises 6% on strong revenue beat and margin gains

RLX Technology delivered a strong Q1 beat, with revenue up 96.2% YoY to RMB1.59 billion versus the RMB1.58 billion consensus and adjusted EPS of $0.26. Gross margin expanded to 31.8% from 28.6%, while adjusted operating income surged 187.9% YoY to RMB310.3 million, driven by international expansion and its May 2025 European acquisition. Shares rose 6.19% pre-market on the results.

Analysis

The cleanest read-through is not just “RLX beats,” but that the business is increasingly behaving like a global consumer hardware/platform hybrid rather than a China-only nicotine proxy. That matters because the mix shift toward international revenue should compress the market’s regulatory discount over time, while the margin expansion suggests the company is gaining pricing power or at least better absorption on logistics and compliance costs. The bigger second-order effect is that a successful overseas rollout raises the competitive bar for smaller regional vape brands that lack scale in licensing, distribution, and product adaptation.

The market is likely underestimating how much of the upside can persist if international expansion becomes self-funding. With cash still ample and operating cash burn contained, RLX has room to keep funding channel buildout, localization, and selective M&A without tapping capital markets, which lowers dilution risk and extends runway through a noisy regulatory backdrop. The key nuance is that the latest quarter likely benefited from policy timing and acquisition contribution; that means sequential growth may slow even if the underlying multi-quarter trend remains intact.

From a risk perspective, the stock is more vulnerable to policy reversals than to demand fatigue. A reversal in export treatment, tighter cross-border compliance, or a slowdown in the acquired European business would hit both revenue and margin simultaneously, making the next 1-2 quarters the critical validation window. The contrarian miss is that the current strength may be more durable than skeptics assume if RLX is building a repeatable international operating model; if so, the rerating can continue for several months as investors reframe it from a domestic policy trade to a global scale story.

Key Decisions for Investors

• Long RLX on pullbacks over the next 1-2 weeks; risk/reward is attractive if the market keeps pricing this as a one-quarter beat rather than a multi-quarter internationalization story. Use a stop on any sign of margin reversal or weaker sequential overseas growth.
• Pair trade: long RLX / short a basket of smaller, regionally concentrated vape or nicotine names over the next 1-3 months. The thesis is that scale, compliance, and distribution are becoming the winning factors, not just category growth.
• Buy RLX call spreads with 2-4 month expiry to express upside while limiting regulatory gap risk. Best structure is modest premium outlay ahead of the next earnings window, where execution on international revenue will matter most.
• If RLX rallies sharply on the print, trim into strength rather than chase. The near-term overhang is the possibility that the quarter captured a policy or acquisition tailwind that is not repeatable at the same magnitude.
• Watch for any read-through on European acquisition integration; if subsequent commentary confirms stable gross margin and no working-capital blowout, add on weakness. If cash burn widens materially, reassess quickly.